Shares of Rentokil Initial plc (LON:RTO) have received a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 406.25 ($5.31).
Several equities analysts have commented on the company. Peel Hunt reiterated a “hold” rating on shares of Rentokil Initial in a report on Monday, July 29th. JPMorgan Chase & Co. increased their price target on Rentokil Initial from GBX 395 ($5.16) to GBX 415 ($5.42) and gave the company an “overweight” rating in a report on Friday, July 26th. Deutsche Bank reiterated a “hold” rating on shares of Rentokil Initial in a report on Thursday, August 1st. Finally, Barclays increased their price target on Rentokil Initial from GBX 350 ($4.57) to GBX 410 ($5.36) and gave the company an “overweight” rating in a report on Thursday, June 27th.
RTO stock traded down GBX 0.80 ($0.01) during midday trading on Friday, hitting GBX 446.10 ($5.83). 1,602,192 shares of the company traded hands, compared to its average volume of 7,450,000. Rentokil Initial has a twelve month low of GBX 280 ($3.66) and a twelve month high of GBX 435.30 ($5.69). The company has a quick ratio of 0.74, a current ratio of 0.83 and a debt-to-equity ratio of 217.72. The firm’s 50 day simple moving average is GBX 420.78. The company has a market cap of $8.31 billion and a PE ratio of -84.17.
About Rentokil Initial
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.
Featured Story: SEC Filing
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.